A single study of peripherin levels using a commercial enzyme-linked immunoassay (ELISA) in patients with motor neuron disease (MND) reported serum peripherin levels were increased in MND compared to control subjects.9 However, the levels of peripherin reported were much higher than expected (measured in ng/ml rather than pg/ml). The gene discussed is PRPH; the disease is mild neurocognitive disorder.